Frankfurt - Delayed Quote EUR
Voyager Therapeutics, Inc. (VT6.F)
2.7000
-0.0200
(-0.74%)
As of 8:19:36 AM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 11 | 11 | 12 | 12 |
| Avg. Estimate | 13.55M | 15.79M | 66.14M | 65.53M |
| Low Estimate | 1M | 1M | 4M | 4M |
| High Estimate | 33M | 36.94M | 146.7M | 146.95M |
| Year Ago Sales | 19.52M | 29.58M | 80M | 66.14M |
| Sales Growth (year/est) | -30.56% | -46.61% | -17.32% | -0.92% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| VT6.F | -- | -- | -- | -- |
| S&P 500 | 7.01% | 4.85% | 8.55% | 14.15% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/8/2025 |
| Maintains | Canaccord Genuity: Buy to Buy | 3/13/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/13/2025 |
| Maintains | Wells Fargo: Overweight to Overweight | 3/12/2025 |
| Reiterates | Wedbush: Outperform to Outperform | 3/12/2025 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 3/12/2025 |
Related Tickers
0K4.F Akero Therapeutics, Inc.
33.55
+1.70%
THER Theralink Technologies, Inc.
0.0001
0.00%
VVY.AS Vivoryon Therapeutics N.V.
1.7900
+2.17%
PRTC.L PureTech Health plc
132.60
+7.46%
CYCN Cyclerion Therapeutics, Inc.
2.9200
+8.15%
ZNTL Zentalis Pharmaceuticals, Inc.
1.4550
+6.99%
VLA.PA Valneva SE
3.1100
+2.44%
GRI GRI Bio, Inc.
1.5000
+2.74%
BTAI BioXcel Therapeutics, Inc.
1.6400
-4.09%
MGNX MacroGenics, Inc.
1.5250
+9.68%